Biontech – booster vaccination pays off – economy

According to a study, a booster vaccination with the vaccine from Biontech / Pfizer restores a high level of vaccination protection. In the examination of more than 10,000 people aged 16 and over who had previously been immunized twice with the Biontech vaccine, the level of vaccination protection after the booster dose was as high as after the second vaccination, said the US Pharmaceutical giant Pfizer and its Mainz partner Biontech joined on Thursday.

According to Pfizer boss Albert Bourla, this is further proof of the benefits of boosters. “These important data complement the evidence that a booster dose of our vaccine can help protect a broad population from this virus and its variants,” said Biontech chief and co-founder Ugur Sahin. “Based on these results, we believe that booster vaccinations, along with widespread global access to vaccines for all, could play an important role in containing the pandemic and returning to normal.”

The Standing Vaccination Commission (Stiko) recommends a Covid-19 booster for people over 70 years of age. The booster with an mRNA vaccine should take place no earlier than six months after completion of the primary vaccination. According to a media report, the US drug agency FDA is about to announce recommendations on Covid-19 booster vaccinations. The authority will advise people over 40 to use a so-called booster with either the vaccine from Biontech / Pfizer or Moderna, reports the broadcaster CNN.